Filter By
Clear all Advanced
I am/have/had
added new label for I am/have/had
more
I am looking for
added new label for I am looking for
more
Advanced Filters
Found 36801 clinical trials
COVID19-Convalescent Plasma for Treating Patients With Active Symptomatic COVID 19 Infection (FALP-COVID)

COVID-19 infection has spread worldwide causing several deaths in few months Convalescent Plasma from COVID 19 donors has shown huge activity in small series from Chinese patients and currently many centers from USA and the European Union are assessing its use looking to avoid mortality and prolonged hospitalizations COVID-19-related

fraction of inspired oxygen (fio2)
chronic disease
hypertension
neutrophil count
chronic obstructive pulmonary disease
  • 0 views
  • 05 Aug, 2020
Sacituzumab Govitecan +/- Pembrolizumab in Metastatic TNBC

This research study involves testing the safety and efficacy of an investigational intervention for patients with triple-negative breast cancer (TNBC) that has spread, or metastasized, to other parts the body and is PD-L1-negative. The names of the study interventions involved in this study are: Sacituzumab govitecan (IMMU-132) Pembrolizumab (Keytruda; MK-3475)

cns disease
corticosteroids
programmed cell death 1 ligand 1
neutrophil count
immunostimulant
  • 8 views
  • 05 Aug, 2020
CPX-351 for the Treatment of Secondary Acute Myeloid Leukemia in Patients Younger Than 60 Years Old

Drugs used in chemotherapy, such as CPX-351, work in different ways to stop the growth of cancer cells, either by killing the cells, by stopping them from dividing, or by stopping them from spreading.

myeloid leukemia
daunorubicin
treatment related aml
myelodysplastic syndrome
myelodysplasia
  • 0 views
  • 16 Feb, 2024
  • 1 location
Ibrutinib + Venetoclax in Untreated WM

This study evaluates the safety and efficacy of Ibrutinib combined with Venetoclax (IVEN) in the treatment of adults diagnosed with Waldenstrom's macroglobulinemia (WM) cancer with a specific MYD88 gene mutation. This research study involves an experimental drug combination of targeted therapies.

waldenstrom's macroglobulinemia
platelet transfusion
igm level
myd88 gene mutation
neutrophil count
  • 0 views
  • 16 Feb, 2024
  • 2 locations
  • 0 views
  • 06 Dec, 2023
  • 2 locations
trial1234567890-

tegvscdkcmldcdhcgvbnm,

  • 0 views
  • 28 Sep, 2023
  • 1 location
  • 0 views
  • 18 Dec, 2023
  • 1 location
A Daily-Activity-Focused, Strategy-Based Educational Programme for Informal Dementia Carers

This study will assess the impact of the Dementia Carer Education Programme on the caregiving burden of informal dementia carers.Ninety informal dementia carers along with their care-recipients will be recruited and randomised to the experimental and control groups. All recruited dementia carers in the experimental group will receive the Dementia …

  • 0 views
  • 16 Jun, 2025
Radiotherapy Plus Nimotuzumab or Cisplatin in Nasopharyngeal Carcinoma

This is a phase III randomized clinical trial of definitive radiotherapy plus EGFR blocker nimotuzumab versus radiotherapy plus cisplatin(CCRT) for nasopharyngeal carcinoma (NPC) patients with favorable response to induction chemotheray(IC), determining whether radiotherapy combined with nimotuzumab was non-inferior to CCRT and may provide new evidence for individualized comprehensive treatment of …

epstein-barr virus dna
EGFR
induction chemotherapy
nasopharyngeal carcinoma
nimotuzumab
  • 0 views
  • 16 Feb, 2024
  • 1 location
Pembrolizumab Plus Paclitaxel Cisplatin Followed by Surgery for Locally Advanced ESCC

The purpose of this study is to observe and evaluate the efficacy and safety of pembrolizumab plus paclitaxel, cisplatin followed by Da Vinci robot radical surgery for locally advanced esophageal squamous cell carcinoma.

squamous cell carcinoma of esophagus
urine test
pembrolizumab injection
serum pregnancy test
cisplatin
  • 0 views
  • 16 Feb, 2024
  • 1 location